SNORA10B: A Potential Drug Target and Biomarker (G109616960)

Target Name: SNORA10B

NCBI ID: G109616960

SNORA10B

Other Name(s): small nucleolar RNA, H/ACA box 10B | Small nucleolar RNA, H/ACA box 10B

SNORA10B: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a class of non-coding RNAs that play a critical role in regulating gene expression in eukaryotic cells. One of the key functional categories of snRNAs is the H/ACA box, which is a conserved region found in the 5' end of many snRNAs. H/ACA boxes are known to be involved in various cellular processes, including DNA replication, transcription, and RNA processing. In this article, we focus on SNORA10B, a H/ACA box RNA molecule that has been identified as a potential drug target and biomarker.

SNORA10B is a 24.1 kilobase (kb) long RNA molecule that is expressed in various tissues and cells, including brain, heart, and muscle. It is primarily localized to the cytoplasm of the cell and is predominantly composed of non-coding RNA. SNORA10B is transcribed from the promoter region located upstream of the start codon, and its expression level can be regulated by various factors, including DNA replication, transcription, and post-transcriptional modifications.

The H/ACA box is a conserved region that is found in the 5' end of many snRNAs. It is composed of 18 amino acid residues and is involved in various cellular processes, including DNA replication, transcription, and RNA processing. The H/ACA box ACA box is a critical region for snRNA function because it is involved in the formation of RNA duplexes, which are important for the regulation of gene expression.

SNORA10B contains a unique H/ACA box that is different from other known H/ACA boxes. It has a unique conservatism, and its structure suggests that it may have unique functions. One of the key features of SNORA10B is its ability to form double -stranded RNA structures. This is important for the regulation of gene expression because RNA duplexes can interact with various protein factors to regulate gene activity.

SNORA10B has also been shown to play a role in the regulation of cellular processes that are important for brain function. For example, studies have shown that SNORA10B is expressed in the brain and is involved in the regulation of various cellular processes that are important for brain development and function. Additionally, SNORA10B has been shown to play a role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

SNORA10B may also be a potential biomarker for various diseases. For example, studies have shown that SNORA10B is expressed in various tissues and cells and is involved in the regulation of various cellular processes that are important for disease development. Additionally, the unique structure of SNORA10B suggests that it may have unique functions that are not yet fully understood.

In conclusion, SNORA10B is a H/ACA box RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and function suggest that it may play a critical role in the regulation of various cellular processes that are important for brain and disease development. Further studies are needed to fully understand the role of SNORA10B in cellular and biological processes.

Protein Name: Small Nucleolar RNA, H/ACA Box 10B

The "SNORA10B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA10B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets